Cypress Bioscience (CYPB +39%) and Forest Labs (FRX +7.5%) get FDA approval for Savella in...


Cypress Bioscience (CYPB +39%) and Forest Labs (FRX +7.5%) get FDA approval for Savella in fibromyalgia treatment. Other stocks that could see an FDA bump: AMAG Pharma (AMAG), BioDelivery Sciences (BDSI), Momenta Pharma (MNTA). (more)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs